BR112016025072A2 - método para a produção de suspensões farmacêuticas líquidas contendo bismuto - Google Patents

método para a produção de suspensões farmacêuticas líquidas contendo bismuto

Info

Publication number
BR112016025072A2
BR112016025072A2 BR112016025072A BR112016025072A BR112016025072A2 BR 112016025072 A2 BR112016025072 A2 BR 112016025072A2 BR 112016025072 A BR112016025072 A BR 112016025072A BR 112016025072 A BR112016025072 A BR 112016025072A BR 112016025072 A2 BR112016025072 A2 BR 112016025072A2
Authority
BR
Brazil
Prior art keywords
liquid pharmaceutical
bismuth
production
containing liquid
pharmaceutical suspensions
Prior art date
Application number
BR112016025072A
Other languages
English (en)
Other versions
BR112016025072B1 (pt
BR112016025072A8 (pt
Inventor
Michael Tunis Adam
Jerome White Daniel Jr
Ho Derrick
Paul V Fitch Edward
Ray Gilbert Steven
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR112016025072A2 publication Critical patent/BR112016025072A2/pt
Publication of BR112016025072A8 publication Critical patent/BR112016025072A8/pt
Publication of BR112016025072B1 publication Critical patent/BR112016025072B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

é provido um método para produção de uma suspensão farmacêutica líquida misturando-se silicato de magnésio e alumínio, goma gelana, subsalicilato de bismuto e metil celulose.
BR112016025072-9A 2014-04-29 2015-04-29 Método para fabricação de suspensões farmacêuticas líquidas e método para produção de uma suspensão BR112016025072B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461985653P 2014-04-29 2014-04-29
US61/985,653 2014-04-29
PCT/US2015/028215 WO2015168241A1 (en) 2014-04-29 2015-04-29 Method for making bismuth-containing liquid pharmaceutical suspensions

Publications (3)

Publication Number Publication Date
BR112016025072A2 true BR112016025072A2 (pt) 2017-08-15
BR112016025072A8 BR112016025072A8 (pt) 2021-07-06
BR112016025072B1 BR112016025072B1 (pt) 2023-06-06

Family

ID=

Also Published As

Publication number Publication date
US10034888B2 (en) 2018-07-31
US20180303852A1 (en) 2018-10-25
ES2682210T3 (es) 2018-09-19
RU2016137537A3 (pt) 2018-05-29
PL3137059T3 (pl) 2018-10-31
CA3041501A1 (en) 2015-11-05
EP3137059B1 (en) 2018-05-23
CA2943420A1 (en) 2015-11-05
US20150306061A1 (en) 2015-10-29
CA2943420C (en) 2019-06-25
US10532063B2 (en) 2020-01-14
AU2015253187A1 (en) 2016-10-13
RU2694530C2 (ru) 2019-07-16
RU2016137537A (ru) 2018-05-29
AU2015253187B2 (en) 2017-10-05
CN106255495A (zh) 2016-12-21
US9486436B2 (en) 2016-11-08
CA3041501C (en) 2020-09-22
US20170027964A1 (en) 2017-02-02
EP3137059A1 (en) 2017-03-08
BR112016025072A8 (pt) 2021-07-06
CN106255495B (zh) 2019-10-22
MX2016013884A (es) 2017-02-02
WO2015168241A1 (en) 2015-11-05
MX370908B (es) 2020-01-08

Similar Documents

Publication Publication Date Title
EP3704477A4 (en) HYDRAULIC FRACTURE MONITORING BY A LOW FREQUENCY DAS
SG11201708632SA (en) Fuel production from catalytic slurry oil
JP2017500760A5 (pt)
BR112017000716A2 (pt) grãos de cerâmica e método para produção destes
MX2016013884A (es) Metodo para fabricar suspensiones farmaceuticas liquidas que contienen bismuto.
EP3481540A4 (en) FORMATION OF COLLOIDS OR GELS IN DROPLETS
MA39748A (fr) Cenicriviroc pour le traitement de la fibrose
BR112017011652A2 (pt) processo para manipulação do nível de teor de glicano de uma glicoproteína
FR3024154B1 (fr) Pneumatique pour avion
EP3173437A4 (en) Method for producing porous cellulose medium
MX355889B (es) Procedimiento para hacer baldosas.
EP3344382A4 (en) AQUEOUS SUSPENSION OF MICROCAPSULES
FR3002237B1 (fr) Methodes pour la production de particules virales aav double brin
EP3161006A4 (en) Assays for vitamin d epimers
EP3134468A4 (en) Template-assisted production of porous materials
MA40690A (fr) Poutre pour grue
FI20155425A (fi) Prosessi nanofibrilliselluloosan hydrogeelin tuottamiseksi
PL3194086T3 (pl) Sposób i instalacja do witryfikacji materiałów włóknistych w trybie ciągłym
EP3178536A4 (en) Defoamer oil compound, production method therefor, and defoamer composition
EP3491249A4 (en) ARRANGEMENT FOR REDUCING THE SIZE OF SUSPENDED SOLIDS
MX2016013886A (es) Suspensiones farmaceuticas liquidas que contienen bismuto.
EP3241309A4 (en) Overprovisioning floating ip addresses to provide stateful ecmp for traffic groups
EP3112310A4 (en) Revolving superstructure for crane
FR3030348B1 (fr) Procede pour l'assemblage d'une ebauche de pneumatique
FR3032617B1 (fr) Procede de preparation d un hydrogel injectable; hydrogel obtenu; utilisation de l hydrogel obtenu

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/04/2015, OBSERVADAS AS CONDICOES LEGAIS